241 related articles for article (PubMed ID: 16521035)
1. 5-HT receptor subtypes involved in the anxiogenic-like action and associated Fos response of acute fluoxetine treatment in rats.
Salchner P; Singewald N
Psychopharmacology (Berl); 2006 Apr; 185(3):282-8. PubMed ID: 16521035
[TBL] [Abstract][Full Text] [Related]
2. Evidence for accelerated desensitisation of 5-HT(2C) receptors following combined treatment with fluoxetine and the 5-HT(1A) receptor antagonist, WAY 100,635, in the rat.
Bristow LJ; O'Connor D; Watts R; Duxon MS; Hutson PH
Neuropharmacology; 2000 Apr; 39(7):1222-36. PubMed ID: 10760364
[TBL] [Abstract][Full Text] [Related]
3. Neuroanatomical substrates involved in the anxiogenic-like effect of acute fluoxetine treatment.
Salchner P; Singewald N
Neuropharmacology; 2002 Dec; 43(8):1238-48. PubMed ID: 12527473
[TBL] [Abstract][Full Text] [Related]
4. Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635.
Bagdy G; Graf M; Anheuer ZE; Modos EA; Kantor S
Int J Neuropsychopharmacol; 2001 Dec; 4(4):399-408. PubMed ID: 11806866
[TBL] [Abstract][Full Text] [Related]
5. alpha(2)-Adrenoceptor involvement in the in vitro inhibitory effect of citalopram on a subpopulation of rat locus coeruleus neurons.
Grandoso L; Torrecilla M; Pineda J; Ugedo L
Eur J Pharmacol; 2005 Jul; 517(1-2):51-8. PubMed ID: 15975573
[TBL] [Abstract][Full Text] [Related]
6. 5-HT2C receptors inhibit and 5-HT1A receptors activate the generation of spike-wave discharges in a genetic rat model of absence epilepsy.
Jakus R; Graf M; Juhasz G; Gerber K; Levay G; Halasz P; Bagdy G
Exp Neurol; 2003 Dec; 184(2):964-72. PubMed ID: 14769389
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of hippocampal 5-HT synthesis by fluoxetine and paroxetine: evidence for the involvement of both 5-HT1A and 5-HT1B/D autoreceptors.
Barton CL; Hutson PH
Synapse; 1999 Jan; 31(1):13-9. PubMed ID: 10025679
[TBL] [Abstract][Full Text] [Related]
8. Modulation of dialysate levels of dopamine, noradrenaline, and serotonin (5-HT) in the frontal cortex of freely-moving rats by (-)-pindolol alone and in association with 5-HT reuptake inhibitors: comparative roles of beta-adrenergic, 5-HT1A, and 5-HT1B receptors.
Gobert A; Millan MJ
Neuropsychopharmacology; 1999 Aug; 21(2):268-84. PubMed ID: 10432475
[TBL] [Abstract][Full Text] [Related]
9. Role of 5-HT1A receptors in the effects of acute chronic fluoxetine on extracellular serotonin in the frontal cortex.
Invernizzi R; Bramante M; Samanin R
Pharmacol Biochem Behav; 1996 May; 54(1):143-7. PubMed ID: 8728551
[TBL] [Abstract][Full Text] [Related]
10. Effects of various serotonin agonists, antagonists, and uptake inhibitors on the discriminative stimulus effects of methamphetamine in rats.
Munzar P; Laufert MD; Kutkat SW; Nováková J; Goldberg SR
J Pharmacol Exp Ther; 1999 Oct; 291(1):239-50. PubMed ID: 10490910
[TBL] [Abstract][Full Text] [Related]
11. Effect of chronic fluoxetine and WAY-100635 treatment on serotonergic neurotransmission in the frontal cortex.
Dawson LA; Nguyen HQ; Smith DL; Schechter LE
J Psychopharmacol; 2002 Jun; 16(2):145-52. PubMed ID: 12095073
[TBL] [Abstract][Full Text] [Related]
12. Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone.
Hughes ZA; Starr KR; Langmead CJ; Hill M; Bartoszyk GD; Hagan JJ; Middlemiss DN; Dawson LA
Eur J Pharmacol; 2005 Mar; 510(1-2):49-57. PubMed ID: 15740724
[TBL] [Abstract][Full Text] [Related]
13. Potentiation of fluoxetine-induced penile erections by combined blockade of 5-HT1A and 5-HT1B receptors.
Millan MJ; Perrin-Monneyron S
Eur J Pharmacol; 1997 Mar; 321(3):R11-3. PubMed ID: 9085055
[TBL] [Abstract][Full Text] [Related]
14. The 5-HT1A and 5-HT2A/2C receptor antagonists WAY-100635 and ritanserin do not attenuate D-fenfluramine-induced fos expression in the brain.
Javed A; Van de Kar LD; Gray TS
Brain Res; 1998 Apr; 791(1-2):67-74. PubMed ID: 9593827
[TBL] [Abstract][Full Text] [Related]
15. The serotonin-1A receptor antagonist WAY-100635 modifies fluoxetine's antidepressant-like profile on the differential reinforcement of low rates 72-s schedule in rats.
Cousins MS; Seiden LS
Psychopharmacology (Berl); 2000 Mar; 148(4):438-42. PubMed ID: 10928318
[TBL] [Abstract][Full Text] [Related]
16. EMD 68843, a serotonin reuptake inhibitor with selective presynaptic 5-HT1A receptor agonistic properties.
Bartoszyk GD; Hegenbart R; Ziegler H
Eur J Pharmacol; 1997 Mar; 322(2-3):147-53. PubMed ID: 9098681
[TBL] [Abstract][Full Text] [Related]
17. Buspirone modulates basal and fluoxetine-stimulated dialysate levels of dopamine, noradrenaline and serotonin in the frontal cortex of freely moving rats: activation of serotonin1A receptors and blockade of alpha2-adrenergic receptors underlie its actions.
Gobert A; Rivet JM; Cistarelli L; Melon C; Millan MJ
Neuroscience; 1999; 93(4):1251-62. PubMed ID: 10501449
[TBL] [Abstract][Full Text] [Related]
18. Additive reduction of alcohol drinking by 5-HT1A antagonist WAY 100635 and serotonin uptake blocker fluoxetine in alcohol-preferring P rats.
Zhou FC; McKinzie DL; Patel TD; Lumeng L; Li TK
Alcohol Clin Exp Res; 1998 Feb; 22(1):266-9. PubMed ID: 9514317
[TBL] [Abstract][Full Text] [Related]
19. Functional and pharmacological characterization of the modulatory role of serotonin on the firing activity of locus coeruleus norepinephrine neurons.
Szabo ST; Blier P
Brain Res; 2001 Dec; 922(1):9-20. PubMed ID: 11730697
[TBL] [Abstract][Full Text] [Related]
20. Potentiation of the fluoxetine-induced increase in dialysate levels of serotonin (5-HT) in the frontal cortex of freely moving rats by combined blockade of 5-HT1A and 5-HT1B receptors with WAY 100,635 and GR 127,935.
Gobert A; Rivet JM; Cistarelli L; Millan MJ
J Neurochem; 1997 Mar; 68(3):1159-63. PubMed ID: 9048762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
